Electronic Titration study: e-T study

• Research type

  Research Study

• Full title

  A 16-week, randomized, open-label, parallel-group study regarding efficacy, patient reported outcomes, and safety when using a titration software medical device in comparison to standard of care titration of insulin glargine U300 in patients with type 2 diabetes

• IRAS ID

  213076

• Contact name

  Samir Purnell-Mullick

• Contact email

  spm@gp-M84019.nhs.uk

• Sponsor organisation

  Sanofi-Aventis Recherche & Développement

• Clinicaltrials.gov Identifier

  DIAB 30767, NIHR CRN reference

• Duration of Study in the UK

  1 years, months, days

• Research summary

  The purpose of this study is to evaluate the efficacy and safety of the web tool, how patients are comfortable with the use of the web tool and how it helps patients in recommending increases or decreases of their insulin dose and thereby keeping their blood glucose level within an acceptable range. This will be compared to standard practice recommendations made by doctors.

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  16/SC/0695

• Date of REC Opinion

  26 Jan 2017

• REC opinion

  Further Information Favourable Opinion